产品开发风险 - 未来产品开发存在风险，可能无法获得市场认可[135] - 产品候选人可能无法获得监管批准或市场接受[136] - 依赖第三方机构进行临床试验可能导致延迟或失败[138] - 未能获得产品的监管批准将限制商业化[139] 股价波动风险 - 公司股价历史波动较大，受多种因素影响[140] - 公司股价可能受多种因素波动，包括产品市场接受度、法律诉讼、财务状况等[141] - 公司股价波动可能导致股东诉讼，影响资本筹集[142] - 公司股票可能会被纳斯达克资本市场摘牌，如果无法维持纳斯达克的持续上市标准[143] 公司治理风险 - 公司是“较小的报告公司”，利用适用于此类公司的减少披露和治理要求，可能导致公司的普通股对投资者不太具吸引力[144] - 公司可能会受到激进股东行动的影响，包括可能发生的董事会选举的代理人竞选[145] 其他风险 - 未解决的员工评论为零[147] - 公司普通股在纳斯达克资本市场交易，截至2022年12月31日，公司普通股的记录股东有26名[149] - 公司从未宣布或支付任何现金股利，目前打算保留所有可用资金和未来收益来支持业务运营和业务增长[151] - 公司未在本年度内出售未注册的股票[152] - 公司未在本年度内回购任何公司普通股，除了为支付员工税收义务而放弃的股票[154] - 公司是较小的报告公司，因此不需要提供有关市场风险的定量和定性披露[203]

Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Michael Grabow - Executive Vice President of Chief Business Officer Thomas Riga - President and Chief Executive Officer Francois J. Lebel - Executive Vice President and Chief Medical Officer Nora Brennan - Executive Vice President and Chief Financial Officer Erin Miller - Senior Vice President Sales and Marketing Conference Call Participants Ed White - H.C. Wainwright Prakhar Agarwal - C ...

Spectrum Pharmaceuticals, Inc. (SPPI) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Michael Grabow - SVP, Corporate Strategy and Operations Thomas J. Riga - President and CEO Francois J. Lebel - EVP and CMO Nora E. Brennan - EVP and CFO Conference Call Participants Unidentified Analyst - Jefferies Ed White - H.C. Wainwright Reni Benjamin - JMP Securities William Wood - B. Riley Securities Prakhar Agarwal - Cantor Fitzgerald Operator Good day and thank you for standing by. ...

Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Michael Grabow - Senior Vice President of Corporate Strategy and Operations Thomas Riga - President and CEO Francois Lebel - Chief Medical Officer Conference Call Participants Maury Raycroft - Jefferies Edward White - H.C. Wainwright Mayank Mamtani - B. Riley Securities Operator Thank you for standing by. And welcome to the Spectrum Pharmaceuticals First Quarter 2022 Earnings Conference Call. A ...

Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2021 Earnings Conference Call March 17, 2022 4:30 PM ET Company Participants Kurt Gustafson - CFO Tom Riga - President & CEO Francois Lebel - EVP & Chief Medical Officer Conference Call Participants Kevin Strang - Jefferies Ed White - H.C. Wainwright Reni Benjamin - JMP Securities Mayank Mamtani - B. Riley Securities FBR Operator Thank you for standing by. And welcome to the Spectrum Pharmaceuticals Fourth Quarter 2021 Earnings Call. At this time, all participants ...